TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1.2	1.3	69.96	2.57	64.87	49.65
Revenue Growth (YoY)	-98.28%	-98.14%	2619.12%	-96.03%	30.67%	208.38%
Cost of Revenue	0	0	1.4	1.4	15.98	6.34
Gross Profit	1.2	1.3	68.57	1.17	48.9	43.31
Selling, General & Admin	7.17	8.9	56.71	80.75	194.01	174.73
Research & Development	0	0	0	0	10.43	19.79
Other Operating Expenses	1.03	0.92	10.67	0	0	0
Operating Expenses	8.2	9.83	67.38	80.75	204.44	194.52
Operating Income	-7	-8.52	1.19	-79.58	-155.54	-151.21
Interest Expense / Income	-0.05	0	0	0	28.58	17.38
Other Expense / Income	0.5	1.8	-110.81	92.84	-0.6	7.56
Pretax Income	-7.45	-10.32	112	-172.42	-183.52	-176.15
Income Tax	-0.04	-0.04	0	0	0	0
Net Income	-7.41	-10.28	112	-172.42	-183.52	-176.15
Shares Outstanding (Basic)	12	10	9	8	6	5
Shares Outstanding (Diluted)	12	10	9	8	6	5
Shares Change	18.23%	11.48%	17.66%	44.39%	11.89%	9.48%
EPS (Basic)	-0.68	-0.98	12.41	-21.66	-33.50	-36.00
EPS (Diluted)	-0.68	-0.98	11.96	-21.66	-33.50	-36.00
Free Cash Flow	-14.73	-48.14	-4.08	-142.73	-159.68	-168.17
Free Cash Flow Per Share	-1.28	-4.61	-0.45	-17.93	-28.96	-34.13
Gross Margin	100.00%	100.00%	98.00%	45.51%	75.37%	87.24%
Operating Margin	-583.65%	-654.61%	1.70%	-3092.77%	-239.77%	-304.56%
Profit Margin	-617.93%	-789.40%	160.08%	-6700.93%	-282.90%	-354.79%
Free Cash Flow Margin	-1228.19%	-3697.47%	-5.83%	-5547.10%	-246.14%	-338.73%
EBITDA	-6.47	-9.4	113.19	-171.68	-150.88	-157.37
EBITDA Margin	-539.95%	-721.89%	161.79%	-6672.33%	-232.57%	-316.98%
Depreciation & Amortization	1.03	0.92	1.19	0.74	4.07	1.39
EBIT	-7.5	-10.32	112	-172.42	-154.94	-158.76
EBIT Margin	-625.69%	-792.70%	160.08%	-6700.93%	-238.84%	-319.78%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).